Evaluation of the Inflammation-Based Modified Glasgow Prognostic Score (mgps) As a Prognostic and Predictive Biomarker in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy: a Post Hoc Analysis of the Randomized Phase III XELAVIRI Trial (AIO KRK0110)
ESMO Open(2024)
关键词
modified Glasgow Prognostic Score,mGPS,metastatic colorectal cancer,gender,XELAVIRI trial
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要